Omics in Urologic Research-New Frontiers Driving Precision Medicine
Omics in Urologic Research-New Frontiers Driving Precision Medicine
批准号:
8832101
负责人:
Allen C Gao
金额:
$1.0万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-08 至 2015-08-31
关键词:
AgeAmericanAreaAutomobile DrivingAwardBasic ScienceBenign Prostatic HypertrophyBiological MarkersBladder DiseasesClinicalClinical ResearchClinical SciencesCollaborationsCommunitiesComplexDataDevelopmentDiagnosisDiagnosticDisciplineDiseaseDisease ProgressionEnsureErectile dysfunctionFacultyFemaleFibrosisFundingFunding OpportunitiesGenderGenitourinary systemGenomicsGoalsHealth Care CostsHumanIndividualInterstitial CystitisKnowledgeLeadMalignant neoplasm of prostateMedicineMinorityModelingMolecular TargetOralPathway interactionsPelvic PainPhysiciansPhysiologicalPopulationPostdoctoral FellowPreventionProcessProteomicsQuality of lifeResearchResearch PersonnelResourcesRestScientistSocietiesSolutionsSourceStudentsSyndromeSystemTechniquesTechnologyTherapeuticTissuesTrainingTranslationsTravelUnderrepresented MinorityUnited StatesUrologic CancerUrologic DiseasesWorkabstractingbasebench to bedsidecareerclinical applicationcontinuing medical educationcostdisease mechanisms studyexperiencefallsfrontiergraduate studenthealth disparityhuman diseasehuman tissueimprovedinnovationinterestlecturesmalemeetingsmembermetabolomicsminority traineemolecular markermultidisciplinarynovelnovel strategiespostersprofessorprognosticpublic health relevancesuccesssymposiumtranscriptomicstreatment responsetreatment strategyurologic
中文摘要
描述(申请人提供):这项R13提案寻求资金,为最有前途的见习调查员提供25次每人500美元的旅行奖励(研究生,居民,临床科学家/博士后培训生和助理教授以下的教员)并增加这一地位的服务不足的少数民族的代表参加和参加2014年秋季研讨会的社会,基础泌尿学研究(SBUR)将于11月13日至16日在德克萨斯州达拉斯举行。该SBUR是一个社会的科学家和医生-科学家专门从事研究的正常和病理条件的组织的人类泌尿生殖道(GU)。GU发育异常和疾病折磨着男性和女性,年轻人和老年人,每年花费美国约110亿美元的医疗费用。年度研讨会的总体目标是在多学科层面上分享新的发现,促进成员和其他感兴趣的科学家之间的互动,激励和促进实习科学家的成功,并突出新的研究领域和资助机会。今年,研讨会的主题是“泌尿学研究中的组学:推动精准医学的新前沿”。“本次研讨会的具体目标是:1)激励年轻和成熟的研究人员利用该领域的现有知识,推进基础和转化泌尿外科研究的前沿; 2)促进和推动泌尿外科研究领域的新研究人员的职业生涯; 3)提供一个论坛,供联网,互动,并在专注于GU发展和疾病的其他学科的研究人员之间建立新的合作,以及4)庆祝卓越,深度,以及本组织成员所从事的基础泌尿学研究的多样性。研讨会期间将涵盖的研究主题包括:组学:从实验室到床边的驱动程序;新兴转录组学和新途径;泌尿系统疾病的模型和差异;泌尿系统疾病的分子标记物和靶点;以及晚期泌尿系统癌症的新兴治疗策略。所有受邀演讲者都是各自领域的领导者,为观众提供广泛的知识和经验。旅行获奖者的选择将通过一个确定的过程进行,申请人由抽象审查小组委员会进行排名,该小组委员会与SBUR的执行理事会合作,向有前途和优秀的培训生申请人颁发个人奖项。执行理事会确保男女在获奖者中的有效代表性,并通过一项具体的运动,寻求代表性不足的少数民族人口的申请人。如果得到资助,该项目将通过提高聪明和有前途的初级调查员、医生-科学家和博士后受训人员和学生的参与,并提高服务不足的少数族裔受训人员参与研究的程度,为会议的教育目标作出贡献。
英文摘要
DESCRIPTION (provided by applicant): This R13 proposal seeks funds to provide 25 travel awards of $500 each to the most promising trainee investigators (Graduate Students, Residents, Clinician-Scientist / Post-Doctoral Trainees and faculty below the rank of Assistant Professor) and to increase representation by Underserved Minorities of this status to attend and participate in the 2014 Annual Fall Symposium of the Society for Basic Urological Research (SBUR) to be held November 13th -16th in Dallas, TX. The SBUR is a society of scientists and physician- scientists specializing in research on the normal and pathological conditions of tissues of the human genitourinary (GU) tract. GU developmental anomalies and diseases afflict males and females, young and old, and cost the US approximately $11 Billion a year in health costs. The overall objective of the annual Symposium is to share new findings at a multidisciplinary level, to promote interaction among members and other interested scientists, to inspire and promote the success of trainee scientists, and to highlight new areas of research and funding opportunities. This year, the theme of the Symposium is "Omics in Urologic Research: New Frontiers Driving Precision Medicine." The specific goals of this Symposium are: 1) to inspire young and established investigators to utilize current knowledge in the field to advance the frontiers of basic and translational urologic research; 2) to promote and advance the careers of new investigators in the field of urologic research; 3) to provide a forum for networking, interaction, and establishing new collaborations between investigators focused in GU development and disease those from other disciplines, and 4) to celebrate the excellence, depth, and diversity of basic urologic research pursued by the members of the organization. Research topics that will be covered during the Symposium include: Omics: Drivers from bench to bedside; Emerging transcriptomics and novel pathways; Models and disparity in urologic diseases; Molecular markers and targets for urologic diseases; and emerging treatment strategies for advanced urologic cancer. All invited speakers are leaders in their respective fields, offering extensive knowledge and experience to the audience. Selection of travel awardees will proceed through a defined process whereby applicants are ranked by the Abstract Review Sub-Committee, which works with the Executive Council of the SBUR to issue individual awards to promising and exceptional Trainee applicants. The Executive Council ensures effective representation of both genders in the awardees and, through a specific campaign, seeks applicants of Underrepresented Minority populations. If funded, this project will contribute to the educational objectives of the meeting by enhancing participation of bright and promising Junior Investigators, Physician-Scientist and Postdoctoral Trainees and Students and increase participation in research by members of underserved minority Trainees.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel therapeutics dual targeting intracrine androgen synthesis and AR for advanced prostate cancer
-
批准号:10573314
-
项目类别:
-
资助金额:$52.11万
-
财政年份:2022
-
负责人:Allen C Gao
-
依托单位:
Novel therapeutics dual targeting intracrine androgen synthesis and AR for advanced prostate cancer
-
批准号:10449648
-
项目类别:
-
资助金额:$54.34万
-
财政年份:2022
-
负责人:Allen C Gao
-
依托单位:
Novel therapeutics dual targeting intracrine androgen synthesis and AR for advanced prostate cancer
-
批准号:10808574
-
项目类别:
-
资助金额:$7.36万
-
财政年份:2022
-
负责人:Allen C Gao
-
依托单位:
Therapeutic targeting steroid sulfatase for advanced prostate cancer
-
批准号:10057773
-
项目类别:
-
资助金额:$38.72万
-
财政年份:2020
-
负责人:Allen C Gao
-
依托单位:
BLR&D Research Career Scientist Award
-
批准号:10618241
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Allen C Gao
-
依托单位:
Therapeutic targeting steroid sulfatase for advanced prostate cancer
-
批准号:10426197
-
项目类别:
-
资助金额:$35.89万
-
财政年份:2020
-
负责人:Allen C Gao
-
依托单位:
Therapeutic targeting Wnt5A signaling for advanced prostate cancer
-
批准号:10526399
-
项目类别:
-
资助金额:$37.4万
-
财政年份:2020
-
负责人:Allen C Gao
-
依托单位:
BLR&D Research Career Scientist Award
-
批准号:10454105
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Allen C Gao
-
依托单位:
Therapeutic targeting steroid sulfatase for advanced prostate cancer
-
批准号:10622544
-
项目类别:
-
资助金额:$35.18万
-
财政年份:2020
-
负责人:Allen C Gao
-
依托单位:
Therapeutic targeting steroid sulfatase for advanced prostate cancer
-
批准号:10737796
-
项目类别:
-
资助金额:$7.66万
-
财政年份:2020
-
负责人:Allen C Gao
-
依托单位:
Therapeutic targeting Wnt5A signaling for advanced prostate cancer
-
批准号:10310519
-
项目类别:
-
资助金额:$37.72万
-
财政年份:2020
-
负责人:Allen C Gao
-
依托单位:
Therapeutic targeting steroid sulfatase for advanced prostate cancer
-
批准号:10598320
-
项目类别:
-
资助金额:$7.33万
-
财政年份:2020
-
负责人:Allen C Gao
-
依托单位:
Targeting AR variants in advanced prostate cancer
-
批准号:10318581
-
项目类别:
-
资助金额:$35.18万
-
财政年份:2019
-
负责人:Allen C Gao
-
依托单位:
Targeting AR variants in advanced prostate cancer
-
批准号:10538636
-
项目类别:
-
资助金额:$35.18万
-
财政年份:2019
-
负责人:Allen C Gao
-
依托单位:
Novel mechanisms of resistance to antiandrogen therapies
-
批准号:10570826
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Allen C Gao
-
依托单位:
Novel mechanisms of resistance to antiandrogen therapies
-
批准号:10266014
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Allen C Gao
-
依托单位:
The role of p52 in prostate cancer
-
批准号:8732152
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Allen C Gao
-
依托单位:
The role of p52 in prostate cancer
-
批准号:8900114
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Allen C Gao
-
依托单位:
The role of p52 in prostate cancer
-
批准号:9339572
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Allen C Gao
-
依托单位:
Novel roles of microRNA in androgen receptor signaling
-
批准号:8634069
-
项目类别:
-
资助金额:$31.09万
-
财政年份:2013
-
负责人:Allen C Gao
-
依托单位:
海外基金